FindMyRecallSubscribe
Class I: serious health riskOngoing

Amneal Pharmaceuticals Sulfamethoxazole and Trimethoprim Tablets Recall

Sulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg, Rx Only, a) 100 Tablets p…

Amneal Pharmaceuticals, LLC · Bridgewater, NJ

Risk level
Class I
Reported by FDA
Jun 18, 2025
Recall ID
D-0488-2025
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals recalled Sulfamethoxazole and Trimethoprim Tablets starting Jun 2, 2025. The FDA classified it as Class I (serious health risk) and published enforcement report D-0488-2025 on Jun 18, 2025. Reason: Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination. Status: Ongoing.

Why it was recalled

Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.

Product description

Sulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg, Rx Only, a) 100 Tablets per Bottle, NDC: 65162-271-10, b) 500 Tablets per Bottle, NDC: 65162-271-50, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad, 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.

Lot numbers, UPCs & expiration codes

Lot #s: a) AM241019, AM241020, Exp. 06/30/2027 b) AM241019A, Exp 06/30/2027

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0488-2025
Classification
Class I
Status
Ongoing
Recall initiated
Jun 2, 2025
FDA report date
Jun 18, 2025
Quantity
6396 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0488-2025, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Ongoing
Country
United States
Event ID
96985
Address
400 Crossing Blvd Fl 3
Code information
Lot #s: a) AM241019, AM241020, Exp. 06/30/2027 b) AM241019A, Exp 06/30/2027
Postal code
08807-2863
Report date
Jun 18, 2025
Product type
Drugs
Recall number
D-0488-2025
Classification
Class I
Recalling firm
Amneal Pharmaceuticals, LLC
Product quantity
6396 bottles
Reason for recall
Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg, Rx Only, a) 100 Tablets per Bottle, NDC: 65162-271-10, b) 500 Tablets per Bottle, NDC: 65162-271-50, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad, 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 2, 2025
Initial firm notification
Press Release
Center classification date
Jun 23, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0488-2025, published Jun 18, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls